Latest News for: asco
Edit
ASCO 2026: Turn Oncology Data into Smarter Trial Strategy, Upcoming Webinar Hosted by Xtalks
PR Newswire 02 Jul 2026
In this free webinar, oncology experts will discuss what ASCO 2026 data could mean for cancer clinical trials and patient care ... TORONTO, July 2, 2026 /PRNewswire/ -- ASCO 2026 marked an important transition in oncology.
Edit
Barby Franco fulmin� a J�sica Cirio tras el esc�ndalo del video con d�lares: "Qu� desilusi�n, asco"
Clarin 25 Jun 2026
Edit
Research Spotlight: Highlights from the ASCO Annual Meeting and Beyond (Pancreatic Cancer Action Network Inc)
Public Technologies 24 Jun 2026
Highlights from the ASCO Annual Meeting and Beyond. I will always remember the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting as the moment the tide turned in the treatment of pancreatic cancer.
Edit
ASCO expands into Qatar to support regional logistics and environmental services growth
Oilfield Technology 23 Jun 2026
Leading logistics, materials and operations management specialist, ASCO, has opened its first office in the Middle East, establishing a new presence in Qatar and strengthening its regional footprint ... .
Edit
ASCO Sets Up Shop in Qatar to Drive Middle East Expansion
MarineLink 23 Jun 2026
Logistics and materials management company ASCO has opened its first office in the Middle East, establishing a presence in Qatar as it looks to expand its regional operations and support growing demand for logistics and environmental services.
Edit
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities ...
Nasdaq Globe Newswire 22 Jun 2026
Edit
Highlights from ASCO 2026 (City of Hope)
Public Technologies 19 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132568103) .
Edit
Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
PR Newswire 17 Jun 2026
and Canada) anti-PD1 therapy, during an oral presentation at the 2026 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago ... This study is supported by the European Innovation Council (EIC) ... SOURCE Nectin Therapeutics, LTD. 21% ... .
Edit
CORRECTING and REPLACING Zetagen Therapeutics Presents Phase 2a Results at ASCO for Investigational ZetaMet™ (Zeta ...
Business Wire 12 Jun 2026
The correct statement is that the study reported no treatment‑related adverse events ... The up .
Edit
On the Edge of Breakthrough: Live from ASCO 2026 — Insights on the latest prostate, lung and multiple myeloma research (City of Hope)
Public Technologies 12 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132452007) .
Edit
First results from the NHS-Galleri trial presented at 2026 ASCO Annual Meeting (King's College London)
Public Technologies 12 Jun 2026
). The NHS-Galleri trial was launched in 2021 and originally led by King's College London Cancer Prevention Trials Unit. It was co-led by former King's academic Professor Peter Sasieni ... She said ... Attachments Original document Permalink. Disclaimer ... (noodl.
Edit
GLP-1 weight-loss drugs might help protect against breast cancer, study presented at ASCO meeting suggests
Chicago Sun-Times 11 Jun 2026
Edit
Oncura Health Physicians Recognized for Research Contributions at ASCO 2026
PR Newswire 11 Jun 2026
Representing Oncura Health at ASCO 2026 were Dr ... Clinical Research Contributions Recognized at ASCO ... The impact of ASCO extended beyond the meeting ... "This was an incredibly productive ASCO," said Dr.
Edit
CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
PR Newswire 11 Jun 2026- 1
- 2
- Next page »